PDCD1 and ovarian carcinoma: In ovarian cancer, the expression of PD-L1 on DCs and macrophages correlates with clinical efficacy of PD-L1 and PD-1 blockade, suggesting that the APC PD-L1 expression may be a predicting factor of therapeutic benefit and patient selection indicator (Lin et al., 2018).